UnknownNot Applicable

Quality Assessment in Exposure Therapy

United States177 participantsStarted 2017-09-13

Plain-language summary

This project will test a measure of treatment quality, Exposure Guide, for therapists using exposure therapy for youths and young adults with anxiety or OCD. We anticipate that users of this measure will be able to complete it reliably, find it acceptable, and that the measure will predict patient outcome. This project will include 40 therapists treating 300 anxious youth and young adults ages 5-25 at a large community mental health agency. Results of this study will establish the Exposure Guide as a measure of exposure quality in real world settings.

Who can participate

Age range5 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient at a Community Mental Health Agency that is partnering with this study * Primary or co-primary diagnosis of OCD, Separation Anxiety, Social Anxiety, Panic Disorder, or Specific Phobia. * Children \< age 12 have a caretaker available to participate in treatment * Patient and parent/legal guardian are English speaking Exclusion Criteria: * Concurrent psychotherapy for treatment of anxiety * Psychosis, Pervasive Developmental Disorder, or Mental Retardation

What they're measuring

Clinical Global Impression Scales

Timeframe: Through study completion, an average of 6 months

Trial details

NCT IDNCT03182101

SponsorBradley Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-01

View on ClinicalTrials.gov More Obsessive-Compulsive Disorder in Children trials